NeuralSTEM Biopharmaceuticals Ltd.
This article was originally published in Start Up
Executive Summary
Many companies have joined the quest for a renewable source of neurons. NeuralSTEM Biopharmaceuticals claims to have identified multipotential neural stem cells, cells capable of deelping into neurons, oligodendrocytes and astrocytes.
You may also be interested in...
Neuronyx Inc.
The time is right to get into the blossoming field of stem cells, believes the high-profile founder of Neuronyx Inc., Hubert Schoemaker, PhD. Fresh from the sale of Centocor, the first-generation biotech that he co-founded, Shoemaker founded Neuronyx in 1999 to develop stem cell-based therapies for neurological disorders.
Planet Neuron: Start-Ups in Neurobiology
New drug discovery tools promise to shorten the distance between mouse and man while new neurology drugs remain on the distant horizon. Meanwhile, licensing keeps start-ups going.
Wound Solutions Ltd.
Wound Solutions Ltd. looks to the paradigm of patient self-care in diabetes to address the gaps in chronic wound care, where the feedback provided by blood glucose monitoring encourages changes in behavior. A small device that is placed under a compression bandage helps patients with venous leg ulcers comply with the steps they should be taking to support wound healing, in the process, collecting data that helps clinicians make informed therapy decisions.